Friday, June 07, 2019 2:01:09 PM
How exciting yet none of them can figure out how to wrap cells in cotton.
Yeah, but the virtual spin on this forum doesn't require cotton. Judd providing paid consulting to PMCB, and suddenly Thermo Fisher Scientific is involved. Where did Kenny announce they have signed a contract with TF to provide consulting?
Then there's the fable of "unmet" need, and how the Kenny wonder treatment will conquer all. Yep a few zaps with the Kenny wonder treatment, in a second line setting, and the tumor will melt off of the artery walls. Something that front line therapies couldn't doo. Sort of begs the question: Why is the mythical CT not to be conducted in a front line setting? Oh yeah, that's right it's too costly. But yet the dreams of the past few days is that TF or the Yuen angel will finance the mythical CT. Frequently the forum spin is all the wraps required.
Yeah, but the virtual spin on this forum doesn't require cotton. Judd providing paid consulting to PMCB, and suddenly Thermo Fisher Scientific is involved. Where did Kenny announce they have signed a contract with TF to provide consulting?
Then there's the fable of "unmet" need, and how the Kenny wonder treatment will conquer all. Yep a few zaps with the Kenny wonder treatment, in a second line setting, and the tumor will melt off of the artery walls. Something that front line therapies couldn't doo. Sort of begs the question: Why is the mythical CT not to be conducted in a front line setting? Oh yeah, that's right it's too costly. But yet the dreams of the past few days is that TF or the Yuen angel will finance the mythical CT. Frequently the forum spin is all the wraps required.
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
